Under normal circumstances, TGF-β has cytostatic effects, but in cancer TGF-β signals via Smad4, which induces expression of platelet derived growth factor B (PDGFB) and thereby glioma proliferation [80]. The gene discussed is TGFB1; the disease is cancer.